Product Application

Chimeric Antigen Receptor T-Cell (CAR-T) therapy represents a revolutionary approach in cancer treatment, involving the engineering of a patient's own T cells to recognize and attack cancer cells. Although CAR-T therapy has demonstrated remarkable efficacy in treating certain hematologic malignancies, its application in solid tumors remains fraught with numerous challenges. Cytokines play a pivotal role in the expansion, survival, and functional modulation of CAR-T cells.

CAR-T (Chimeric Antigen Receptor T-cell) therapy, in brief, involves the in vitro modification of T cells derived from cancer patients or allogeneic sources. These T cells are engineered to express a CAR structure, enabling them to recognize target cell antigens. Upon activation, they recruit other immune cells to eliminate tumors, thereby achieving the goal of treating cancer and other diseases.